Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Journal of Thoracic Disease|June 17, 2024
Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective studyJiazhuo Tang, Yang Fu, Yuxiao Song, et al.EMBO Molecular Medicine|July 11, 2020
Systemic CD4 immunity: A powerful clinical biomarker for PD-L1/PD-1 immunotherapyMiren Zuazo, Hugo Arasanz, Ana Bocanegra, et al.Archivum Immunologiae Et Therapiae Experimentalis|October 17, 2017
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future PerspectivesMaria Ibáñez-Vea, Miren Zuazo, Maria Gato, et al.Frontiers in Immunology|December 17, 2020
Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy EfficacyMiren Zuazo, Hugo Arasanz, Ana Bocanegra, et al.Oncotarget|September 9, 2017
PD1 signal transduction pathways in T cellsHugo Arasanz, Maria Gato-Cañas, Miren Zuazo, et al.Annals of Translational Medicine|November 9, 2017
Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapyMiren Zuazo, Maria Gato-Cañas, Noelia Llorente, et al.Immunotherapy|May 4, 2016
Novel immunotherapies for the treatment of melanomaMaria Gato-Cañas, Hugo Arasanz, Idoia Blanco-Luquin, et al.Signal Transduction and Targeted Therapy|October 3, 2018
The intracellular signalosome of PD-L1 in cancer cellsDavid Escors, María Gato-Cañas, Miren Zuazo, et al.Discovery Medicine|April 27, 2025
CAR-T Therapy for the Treatment of Colorectal CancerArturo Lecumberri, Hugo Arasanz, Irene Caseda, et al.Cancers|March 11, 2023
State of the Art: ctDNA in Upper Gastrointestinal MalignanciesIbone Labiano, Ana Elsa Huerta, Virginia Arrazubi, et al.Pageof 5